Zecotek Photonics (ZMSPF) 0.2118 $ZMSPF
Zecotek Increases Non-Brokered Private Placement to $1,574,799
ACCESSWIRE - Tue Jun 14, 6:09PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / June 14, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has increased the non-brokered private placement, announced on May 9, 2016, to $1,574,799.
ZMS.VN: 0.280 (unch)
Zecotek Increases Non-Brokered Private Placement to $925,000 and Closes First Tranche of $678,000
ACCESSWIRE - Thu May 26, 8:12AM CDT
SINGAPORE / ACCESSWIRE / May 26, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I) (the "Company"
, a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has increased the non-brokered private placement announced on May 19, 2016 to $925,000. The Company also announced it has closed on the first tranche of the private placement by selling 2,259,997 units of the Company at a price of $0.30 per unit for gross proceeds of $678,000.
ZMS.VN: 0.280 (unch)
Zecotek Announces Non-Brokered Private Placement
ACCESSWIRE - Thu May 19, 4:00PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / May 19, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has arranged for a non-brokered private placement of 2,250,000 units of the Company at a price of $0.30 per unit for gross proceeds of $675,000.
ZMS.VN: 0.280 (unch)
Chinese OEM Receives First Order of Patented LFS Scintillation Crystals
PR Newswire - Thu May 05, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the major medical OEM based in China, which selected Zecotek's patented lutetium fine silicate (LFS) scintillation crystals for a new line of high resolution positron emission tomography (PET) medical imaging devices, has received the first order of LFS scintillation crystals. As previously announced on March 23, 2016, Zecotek Imaging Systems signed a memorandum of understanding (MOU) with the medical OEM to purchase LFS scintillation crystals. The MOU contains two conditions that when met, will lead to a contractual agreement. The first condition is the delivery and receipt of the LFS crystals by the end of April 2016, and the second is the installation of the first LFS based PET scanner in a Shanghai clinic by early summer.
ZMS.VN: 0.280 (unch)
Zecotek Reports $685,452 of LFS Scintillation Crystal Sales Revenue For Third Quarter Fiscal 2016
CNW Group - Fri Apr 29, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today reported preliminary unaudited revenue for the third quarter ending April 30, 2016. Sales for the third quarter were $685,452, a ninefold increase from $70,149 posted in the same time period last year. Unaudited revenue for the nine months ending April 30, 2016 increased $1,288,726 to $1,532,406 from $243,680 in fiscal 2015.
ZMS.VN: 0.280 (unch)
PET Program at CERN Selects and Orders LFS Crystals
CNW Group - Thu Apr 21, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the Positron Emission Tomography (PET) program at European Organization for Nuclear Physics (CERN) has selected and ordered its patented LFS scintillation crystals for its work on PET medical scanning devices. After a long process of testing, Zecotek`s LFS scintillation crystals were chosen because they provide the best results for coincidence timing resolution. The LFS technology and formulation also present an intrinsic capability and ability for the future development of even higher performance LFS versions as compared to any competing crystals.
ZMS.VN: 0.280 (unch)
Zecotek Receives First Patent for New Advanced Formulation of its Worldwide Patented LFS Scintillation Crystals
PR Newswire - Wed Apr 06, 8:26AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that its wholly owned division, Zecotek Imaging Systems Pte. Ltd., has been granted its first patent in a series of pending patents for its advanced formulation of its patented LFS scintillation crystals. The patent is for multi-doped lutetium oxide based scintillators having improved photonic properties.
ZMS.VN: 0.280 (unch)
Zecotek Announces Significant Opportunity for LFS Scintillation Crystals and Enters Radiation Safety and Homeland Security Market Due to World Events and Demand by OEMs
PR Newswire - Fri Apr 01, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that it has received preliminary orders for its patented Lutetium Fine Silicate (LFS) scintillation crystals from major OEMs developing radiation monitoring and detection devices. The LFS crystals will be tested in devices used in homeland security and border protection and safety, specifically border security, land crossings, airports, harbours and strategic government buildings.
ZMS.VN: 0.280 (unch)
Chinese OEM Adopts Zecotek's LFS Scintillation Crystal for New Line of Positron Emission Tomography Medical Scanning Devices
CNW Group - Wed Mar 23, 7:30AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that a major medical OEM based in China has selected Zecotek's patented lutetium fine silicate (LFS) scintillation crystals for a new line of high resolution positron emission tomography (PET) medical imaging devices. It is anticipated that the first high resolution PET medical imaging device using Zecotek's LFS crystals will be installed in a Shanghai hospital in July 2016.
ZMS.VN: 0.280 (unch)
Zecotek Closes Second Tranche of $1.6 Million Private Placement
ACCESSWIRE - Thu Feb 04, 3:36PM CST
SINGAPORE, SINGAPORE / ACCESSWIRE / February 4, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I) (the "Company", a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it has closed on the second tranche of the private placement, announced on December 9, 2015, by selling 1,301,889 units of the Company at a price of $0.36 per unit for gross proceeds of $468,680. The Company sold an aggregate of 4,385,889 units at a price of $0.36 for total gross proceeds of $1,578,920.
ZMS.VN: 0.280 (unch)
Zecotek Reports $622,817 of LFS Scintillation Crystal Sales Revenue for Second Quarter 2016
PR Newswire - Tue Feb 02, 8:00AM CST
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today reported preliminary unaudited revenue for the second quarter ended January 31, 2016. Sales for the second quarter were a record $622,817, a threefold increase from $149,589 recorded in the first quarter of fiscal 2016, and a sevenfold increase compared to the same time period last year. Unaudited revenue for the six months ending January 31, 2016 increased $598,875 to $772,406 from $173,531 for fiscal 2015.
ZMS.VN: 0.280 (unch)
Zecotek Increases Non-Brokered Private Placement to $1,574,799
ACCESSWIRE - Tue Jun 14, 6:09PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / June 14, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has increased the non-brokered private placement, announced on May 9, 2016, to $1,574,799.
ZMS.VN: 0.280 (unch)
Zecotek Increases Non-Brokered Private Placement to $925,000 and Closes First Tranche of $678,000
ACCESSWIRE - Thu May 26, 8:12AM CDT
SINGAPORE / ACCESSWIRE / May 26, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I) (the "Company"
, a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has increased the non-brokered private placement announced on May 19, 2016 to $925,000. The Company also announced it has closed on the first tranche of the private placement by selling 2,259,997 units of the Company at a price of $0.30 per unit for gross proceeds of $678,000. ZMS.VN: 0.280 (unch)
Zecotek Announces Non-Brokered Private Placement
ACCESSWIRE - Thu May 19, 4:00PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / May 19, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has arranged for a non-brokered private placement of 2,250,000 units of the Company at a price of $0.30 per unit for gross proceeds of $675,000.
ZMS.VN: 0.280 (unch)
Chinese OEM Receives First Order of Patented LFS Scintillation Crystals
PR Newswire - Thu May 05, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the major medical OEM based in China, which selected Zecotek's patented lutetium fine silicate (LFS) scintillation crystals for a new line of high resolution positron emission tomography (PET) medical imaging devices, has received the first order of LFS scintillation crystals. As previously announced on March 23, 2016, Zecotek Imaging Systems signed a memorandum of understanding (MOU) with the medical OEM to purchase LFS scintillation crystals. The MOU contains two conditions that when met, will lead to a contractual agreement. The first condition is the delivery and receipt of the LFS crystals by the end of April 2016, and the second is the installation of the first LFS based PET scanner in a Shanghai clinic by early summer.
ZMS.VN: 0.280 (unch)
Zecotek Reports $685,452 of LFS Scintillation Crystal Sales Revenue For Third Quarter Fiscal 2016
CNW Group - Fri Apr 29, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today reported preliminary unaudited revenue for the third quarter ending April 30, 2016. Sales for the third quarter were $685,452, a ninefold increase from $70,149 posted in the same time period last year. Unaudited revenue for the nine months ending April 30, 2016 increased $1,288,726 to $1,532,406 from $243,680 in fiscal 2015.
ZMS.VN: 0.280 (unch)
PET Program at CERN Selects and Orders LFS Crystals
CNW Group - Thu Apr 21, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the Positron Emission Tomography (PET) program at European Organization for Nuclear Physics (CERN) has selected and ordered its patented LFS scintillation crystals for its work on PET medical scanning devices. After a long process of testing, Zecotek`s LFS scintillation crystals were chosen because they provide the best results for coincidence timing resolution. The LFS technology and formulation also present an intrinsic capability and ability for the future development of even higher performance LFS versions as compared to any competing crystals.
ZMS.VN: 0.280 (unch)
Zecotek Receives First Patent for New Advanced Formulation of its Worldwide Patented LFS Scintillation Crystals
PR Newswire - Wed Apr 06, 8:26AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that its wholly owned division, Zecotek Imaging Systems Pte. Ltd., has been granted its first patent in a series of pending patents for its advanced formulation of its patented LFS scintillation crystals. The patent is for multi-doped lutetium oxide based scintillators having improved photonic properties.
ZMS.VN: 0.280 (unch)
Zecotek Announces Significant Opportunity for LFS Scintillation Crystals and Enters Radiation Safety and Homeland Security Market Due to World Events and Demand by OEMs
PR Newswire - Fri Apr 01, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that it has received preliminary orders for its patented Lutetium Fine Silicate (LFS) scintillation crystals from major OEMs developing radiation monitoring and detection devices. The LFS crystals will be tested in devices used in homeland security and border protection and safety, specifically border security, land crossings, airports, harbours and strategic government buildings.
ZMS.VN: 0.280 (unch)
Chinese OEM Adopts Zecotek's LFS Scintillation Crystal for New Line of Positron Emission Tomography Medical Scanning Devices
CNW Group - Wed Mar 23, 7:30AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that a major medical OEM based in China has selected Zecotek's patented lutetium fine silicate (LFS) scintillation crystals for a new line of high resolution positron emission tomography (PET) medical imaging devices. It is anticipated that the first high resolution PET medical imaging device using Zecotek's LFS crystals will be installed in a Shanghai hospital in July 2016.
ZMS.VN: 0.280 (unch)
Zecotek Closes Second Tranche of $1.6 Million Private Placement
ACCESSWIRE - Thu Feb 04, 3:36PM CST
SINGAPORE, SINGAPORE / ACCESSWIRE / February 4, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I) (the "Company"
, a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it has closed on the second tranche of the private placement, announced on December 9, 2015, by selling 1,301,889 units of the Company at a price of $0.36 per unit for gross proceeds of $468,680. The Company sold an aggregate of 4,385,889 units at a price of $0.36 for total gross proceeds of $1,578,920. ZMS.VN: 0.280 (unch)
Zecotek Reports $622,817 of LFS Scintillation Crystal Sales Revenue for Second Quarter 2016
PR Newswire - Tue Feb 02, 8:00AM CST
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today reported preliminary unaudited revenue for the second quarter ended January 31, 2016. Sales for the second quarter were a record $622,817, a threefold increase from $149,589 recorded in the first quarter of fiscal 2016, and a sevenfold increase compared to the same time period last year. Unaudited revenue for the six months ending January 31, 2016 increased $598,875 to $772,406 from $173,531 for fiscal 2015.
ZMS.VN: 0.280 (unch)
